Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer.
Bosch-Barrera J, Verdura S, Ruffinelli JC, Carcereny E, Sais E, Cuyàs E, Palmero R, Lopez-Bonet E, Hernández-Martínez A, Oliveras G, Buxó M, Izquierdo A, Morán T, Nadal E, Menendez JA.
Bosch-Barrera J, et al. Among authors: lopez bonet e.
Cancers (Basel). 2021 Aug 19;13(16):4168. doi: 10.3390/cancers13164168.
Cancers (Basel). 2021.
PMID: 34439322
Free PMC article.